Valvular heart disease (VHD) is a major contributor to loss of physical function, quality of life
and longevity. The epidemiology of VHD varies substantially around the world, with a …

Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

Heightened interest in tricuspid regurgitation (TR) stems from the consistent association of
mortality with greater severity of TR, and a low use of surgical solutions in the setting of high …

In minimally invasive endovascular procedures, surgeons rely on catheters with low
dexterity and high aspect ratios to reach an anatomical target. However, the environment …

Background: Tricuspid regurgitation is associated with increased rates of heart failure (HF)
and mortality. Transcatheter tricuspid valve interventions (TTVI) are promising, but the …

Background Tricuspid regurgitation is a prevalent disease associated with high morbidity
and mortality, with few treatment options. The aim of the TRILUMINATE trial is to evaluate …

Aims The aim of this study was to identify determinants of in-hospital and mid-term outcomes
after isolated tricuspid valve surgery (ITVS) and more specifically the impact of tricuspid …

Background: Functional tricuspid regurgitation (FTR) is common in heart failure with reduced
ejection fraction and mostly consequent to pulmonary hypertension. However, the intrinsic …

Background: Severe tricuspid regurgitation (TR) is associated with high morbidity and
mortality rates with limited treatment options. Objectives: The authors report the 6-month …

Aims Patients with pulmonary hypertension (PHT) are often excluded from surgical therapies
for tricuspid regurgitation (TR). Transcatheter tricuspid valve repair (TTVR) with the …